Hybio Pharmaceutical (300199) — Financial Flexibility Index
Hybio Pharmaceutical (300199) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥213.38 Million (operating CF CN¥117.78 Million minus capex CN¥95.60 Million) represents 0% of total liabilities (CN¥2.50 Billion). Check Hybio Pharmaceutical strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hybio Pharmaceutical Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Hybio Pharmaceutical across 18 annual periods. See Hybio Pharmaceutical working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hybio Pharmaceutical (2007–2024)
Year-by-year free cash flow to debt coverage for Hybio Pharmaceutical. For the full company profile including market capitalisation, see 300199 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥280.54 Million | CN¥164.71 Million | CN¥2.41 Billion | ▲ +270.9% |
| 2023 | 0.03x | CN¥78.23 Million | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -64.7% |
| 2022 | 0.09x | CN¥205.65 Million | CN¥15.81 Million | CN¥2.31 Billion | ▼ -43.6% |
| 2021 | 0.16x | CN¥355.83 Million | CN¥156.83 Million | CN¥2.26 Billion | ▲ +26.5% |
| 2020 | 0.12x | CN¥291.65 Million | CN¥47.99 Million | CN¥2.34 Billion | ▼ -54.0% |
| 2019 | 0.27x | CN¥674.79 Million | CN¥104.64 Million | CN¥2.49 Billion | ▲ +48.9% |
| 2018 | 0.18x | CN¥412.57 Million | CN¥47.00 Million | CN¥2.27 Billion | ▼ -40.9% |
| 2017 | 0.31x | CN¥434.88 Million | CN¥213.74 Million | CN¥1.41 Billion | ▼ -36.4% |
| 2016 | 0.48x | CN¥412.46 Million | CN¥296.41 Million | CN¥852.42 Million | ▼ -11.7% |
| 2015 | 0.55x | CN¥497.82 Million | CN¥138.84 Million | CN¥908.68 Million | ▼ -7.8% |
| 2014 | 0.59x | CN¥238.59 Million | CN¥153.43 Million | CN¥401.32 Million | ▼ -78.6% |
| 2013 | 2.77x | CN¥456.33 Million | CN¥153.48 Million | CN¥164.48 Million | ▼ -3.4% |
| 2012 | 2.87x | CN¥308.57 Million | CN¥87.19 Million | CN¥107.42 Million | ▲ +13.5% |
| 2011 | 2.53x | CN¥150.74 Million | CN¥72.48 Million | CN¥59.56 Million | ▲ +5.5% |
| 2010 | 2.40x | CN¥77.52 Million | CN¥54.69 Million | CN¥32.30 Million | ▲ +274.1% |
| 2009 | 0.64x | CN¥35.11 Million | CN¥26.11 Million | CN¥54.73 Million | ▼ -77.4% |
| 2008 | 2.84x | CN¥106.02 Million | CN¥45.75 Million | CN¥37.32 Million | ▼ -49.7% |
| 2007 | 5.65x | CN¥53.93 Million | CN¥49.04 Million | CN¥9.54 Million | — |